I
INBX
Inhibrx Biosciences Inc
93.38
-3.72-3.83%After Hours: 93.38 0.00 0.00%16:10 10/23 EDT
OPEN/PREV CLOSE96.96/97.10
TODAY RANGE92.50-96.99
VOL176.22K
MARKET CAP1.37B
52 WEEK RANGE28.16-155.29
AVG VOL (3M)279.01K
% TURNOVER1.09%
TURNOVER--
P/E (TTM)-10.5204
% RANGE4.38%
EPS(TTM)-8.8761
P/E(FORWARD)-9.5318
P/B-25.9266
BVPS-3.6017
DIVIDEND--
P/S1,046.86
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP935.90M
SHARES OUTSTANDING14.72M
NEXT EARNINGS11/12-11/16
FREE FLOAT10.02M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·10/15 02:01
CEO’s Bold Insider Move Signals Growing Confidence in Biotech Player
Simply Wall St·10/14 16:21
Learn Why The Bull Case For Inhibrx Biosciences Stock Could Change Following Conference Data Presentations
PR Newswire·10/13 20:00
Inhibrx Announces Participation in Upcoming Scientific Conferences
Simply Wall St·09/29 15:13
Inhibrx Biosciences (INBX) Shares Moved, What Is Driving Attention Now?
TipRanks·09/29 02:01
CEO’s Bold Move Signals Growing Confidence in Biotech Challenger
TipRanks·09/28 22:15
Inhibrx CEO buys $998.8K in common stock as part of option exercise
TipRanks·09/28 21:27
Inhibrx Biosciences Updates Investor Presentation and Pipeline Outlook
TipRanks·09/24 02:04
Top Insider Makes Bold Move on Biotech Stock
TipRanks·09/23 23:55
Closing Bell Movers: Stitch Fix down 18% after results and guidance
TipRanks·09/23 23:05
Inhibrx director buys $500K in common stock
TipRanks·09/18 02:03
Top Insider Makes Bold Move at Inhibrx Biosciences
TipRanks·09/16 02:03
Insider Shake-Up at Inhibrx Biosciences Sparks Investor Attention
Simply Wall St·09/15 09:23
Learn Why The Bull Case For Inhibrx Biosciences (INBX) Could Change Following Phase 2 Cancer Trial Results
Same Industry
Name/Symbol
Change%
Price